Efficacy and Safety of Granisteron Versus Metoclopramide as Prophylaxis Antiemetic in Laparoscopic Cholecystectomy

NCT04899817 Phase 4 UNKNOWN

Study aims at comparing the effect of granisteron with that of metoclopramide in patients undergoing lab cholecystectomy

Details

Lead sponsor	Assiut University
Phase	Phase 4
Status	UNKNOWN
Enrolment	60
Start date	2021-05
Completion	2022-04

Conditions

• Nausea and Vomiting, Postoperative

Interventions

• Granisetron

Primary outcomes

• Postoperative nausea and vomitting — Every 2 hours for 12 hours
  Number of attacks of nausea and vomitting

Countries

Egypt